SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 115 filers reported holding SUTRO BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $70,861 | -85.1% | 20,421 | -80.1% | 0.00% | -83.3% |
Q2 2023 | $476,848 | -43.6% | 102,548 | -43.9% | 0.01% | -47.8% |
Q1 2023 | $844,832 | -32.2% | 182,864 | +18.6% | 0.02% | -34.3% |
Q4 2022 | $1,245,984 | +288.2% | 154,206 | +166.5% | 0.04% | +218.2% |
Q3 2022 | $321,000 | +53.6% | 57,869 | +312.1% | 0.01% | -15.4% |
Q4 2021 | $209,000 | -17.4% | 14,041 | -56.9% | 0.01% | -27.8% |
Q2 2020 | $253,000 | +125.9% | 32,601 | +219.1% | 0.02% | +157.1% |
Q4 2019 | $112,000 | – | 10,215 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 1,675,579 | $5,814,259 | 1.78% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 5,883,693 | $20,416,415 | 1.10% |
Kynam Capital Management, LP | 1,552,675 | $5,387,782 | 0.88% |
Parkman Healthcare Partners LLC | 1,182,168 | $4,102,123 | 0.75% |
Rubric Capital Management LP | 3,344,810 | $11,606,491 | 0.44% |
BVF INC/IL | 3,347,946 | $11,617,373 | 0.31% |
DAFNA Capital Management LLC | 283,079 | $982,284 | 0.31% |
SECTORAL ASSET MANAGEMENT INC | 432,339 | $1,500,216 | 0.29% |
Eversept Partners, LP | 769,638 | $2,670,644 | 0.23% |
Frazier Life Sciences Management, L.P. | 780,000 | $2,706,600 | 0.18% |